lenalidomide has been researched along with Histiocytosis, Sinus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Liu, T | 1 |
| Balme, B; Benzerdjeb, N; Boutin, AB; Donzel, M; Émile, JF; Fiani, DJ; Fontaine, J; Istier, L; Traverse-Glehen, A; Tychyj, C | 1 |
| Assal, A; Elman, J; Janakiram, M; Mohammadi, F; Rubinstein, M; Scherba, M; Strakhan, M; Verma, A; White, R | 1 |
3 other study(ies) available for lenalidomide and Histiocytosis, Sinus
| Article | Year |
|---|---|
Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report.
Topics: Dexamethasone; Diagnosis, Differential; Histiocytosis, Sinus; Humans; Lenalidomide | 2022 |
[Rosai-Dorfman-Destombes disease with a misleading laryngeal presentation].
Topics: Dexamethasone; Histiocytes; Histiocytosis, Sinus; Humans; Lenalidomide; Plasma Cells | 2022 |
Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.
Topics: Adult; Histiocytosis, Sinus; Humans; Immunologic Factors; Lenalidomide; Male; Thalidomide; Treatment Outcome | 2016 |